Bacteremia caused by Pantoea agglomerans at a medical center in Taiwan, 2000-2010

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 3, 2013, Pages 187-194

  Cheng, Aristine ^a,b   Liu, Chia Ying ^a   Tsai, Hsih Yeh ^a,b   Hsu, Meng Shuian ^a   Yang, Chia Jui ^a   Huang, Yu Tsung ^a,b   Liao, Chun Hsing ^a   Hsueh, Po Ren ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

16S rRNA gene sequence analysis; Antimicrobial susceptibilities; Bacteremia; Pantoea agglomerans

Indexed keywords

ANTACID AGENT; CEFAZOLIN; FOSFOMYCIN; RNA 16S;

ADULT; ADVANCED CANCER; ADVERSE OUTCOME; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISEASE SEVERITY; ESOPHAGITIS; FEMALE; GENE SEQUENCE; HUMAN; HYPOTENSION; INDWELLING CATHETER; MALE; MEDICAL RECORD REVIEW; PANTOEA AGGLOMERANS; RECURRENT DISEASE; STOMACH DISEASE; TAIWAN; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; ANTACIDS; BACTEREMIA; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PANTOEA; RISK FACTORS; TAIWAN;

EID: 84879260114     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.05.005     Document Type: Article

References (30)

1. Delétoile A., Decré D., Courant S., Passet V., Audo J., Grimont P., et al. Phylogeny and identification of Pantoea species and typing of Pantoea agglomerans strains by multilocus gene sequencing. J Clin Microbiol 2009, 47:300-310.
2. Rezzonico F., Smits T.H., Montesinos E., Frey J.E., Duffy B. Genotypic comparison of Pantoea agglomerans plant and clinical strains. BMC Microbiol 2009, 9:204.
3. Volksch B., Thon S., Jacobsen I.D., Gube M. Polyphasic study of plant- and clinic-associated Pantoea agglomerans strains reveals indistinguishable virulence potential. Infect Genet Evol 2009, 9:1381-1391.
4. Bicudo E.L., Macedo V.O., Carrara M.A., Castro F.F., Rage R.I. Nosocomial outbreak of Pantoea agglomerans in a pediatric urgent care centre. Braz J Infect Dis 2007, 11:281-284.
5. Cruz A.T., Cazacu A.C., Allen C.H. Pantoea agglomerans, a plant pathogen causing human disease. J Clin Microbiol 2007, 45:1989-1992.
6. Liberto M.C., Matera G., Puccio R., Lo Russo T., Colosimo E., Foca E. Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital. New Microbiol 2009, 32:119-123.
7. Christakis G.B., Perlorentzou S.P., Aslanidou M., Savva L., Zarkadis I.K. Bacteremia caused by Pantoea agglomerans and Enterococcus faecalis in a patient with colon cancer. J BUON 2007, 12:287-290.
8. Fullerton D.G., Lwin A.A., Lal S. Pantoea agglomerans liver abscess presenting with a painful thigh. Euro J Gastroenterol Hepatol 2007, 19:433-435.
9. Uche A. Pantoea agglomerans bacteremia in a 65-year-old man with acute myeloid leukemia: case report and review. South Med J 2008, 101:102-103.
10. Braun-Kiewnick A., Jacobsen B.J., Sands D.C. Biological control of Pseudomonas syringae pv. syringae, the causal agent of Basal Kernel Blight of Barley, by antagonistic Pantoea agglomerans. Phytopathology 2000, 90:368-375.
11. Plaza P., Usall J., Smilanick J.L., Lamarca N., Vinas I. Combining Pantoea agglomerans (CPA-2) and curing treatments to control established infections of Penicillium digitatum on lemons. JFood Prot 2004, 67:781-786.
12. Kohchi C., Inagawa H., Nishizawa T., Yamaguchi T., Nagai S., Soma G. Applications of lipopolysaccharide derived from Pantoea agglomerans (IP-PA1) for health care based on macrophage network theory. J Biosci Bioeng 2006, 102:485-496.
13. Nakata K., Inagawa H., Soma G. Lipopolysaccharide IP-PA1 from Pantoea agglomerans prevents suppression of macrophage function in stress-induced diseases. Anticancer Res 2011, 31:2437-2440.
14. Lai C.C., Cheng A., Huang Y.T., Chung K.P., Lee M.R., Liao C.H., et al. Escherichia fergusonii bacteremia in a diabetic patient with pancreatic cancer. J Clin Microbiol 2011, 49:4001-4002.
15. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement. M100-S20 2010, CLSI, Wayne, PA, 2010.
16. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
17. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens G., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004, 140:26-32.
18. Foundation T.B.S. [accessed 28.06.2012]. http://www.blood.org.tw/Internet/english/.
19. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
20. Van Rostenberghe H., Noraida R., Wan Pauzi W.I., Habsah H., Zeehaida M., Rosliza A.R., et al. The clinical picture of neonatal infection with Pantoea species. Jap J Infect Dis 2006, 59:120-121.
21. Torrado J., Ruiz B., Garay J., Cosme A., Arenas J.I., Bravo J.C., et al. Lewis, secretor, and ABO phenotypes, and sulfomucin expression in gastric intestinal metaplasia. Cancer Epidemiol Biomarkers Prev 1997, 6:287-289.
22. Hoskins L.C., Zamcheck N. Studies on gastric mucus in health and disease. Ii. Evidence for a correlation between Abo blood group specificity, Abh(O) secretor status, and the fucose content of the glycoproteins elaborated by the gastric mucosa. Gastroenterology 1965, 48:758-767.
23. De Champs C., Le Seaux S., Dubost J.J., Boisgard S., Sauvezie B., Sirot J. Isolation of Pantoea agglomerans in two cases of septic monoarthritis after plant thorn and wood sliver injuries. J Clin Microbiol 2000, 38:460-461.
24. Ferrantino M., Navaneethan S.D., Sloand J.A. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int 2008, 28:428-430.
25. Kratz A., Greenberg D., Barki Y., Cohen E., Lifshitz M. Pantoea agglomerans as a cause of septic arthritis after palm tree thorn injury; case report and literature review. Arch Dis Child 2003, 88:542-544.
26. Ulloa-Gutierrez R., Moya T., Avila-Aguero M.L. Pantoea agglomerans and thorn-associated suppurative arthritis. Pediatr Infect Dis J 2004, 23:690.
27. Shubov A., Jagannathan P., Chin-Hong P.V. Pantoea agglomerans pneumonia in a heart-lung transplant recipient: case report and a review of an emerging pathogen in immunocompromised hosts. Transpl Infect Dis 2011, 13:536-539.
28. Janda J.M., Abbott S.L. 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol 2007, 45:2761-2764.
29. Hebishima T., Matsumoto Y., Watanabe G., Soma G., Kohchi C., Taya T., et al. Protective effects of the immunopotentiator from Pantoea agglomerans 1 on chemotherapeutic agent-induced macrophage growth inhibition. Anticancer Res 2010, 30:2033-2040.
30. Hebishima T., Matsumoto Y., Watanabe G., Soma G., Kohchi C., Taya K., et al. Oral administration of immunopotentiator from Pantoea agglomerans 1 (IP-PA1) improves the survival of B16 melanoma-inoculated model mice. Exp Anim 2011, 60:101-109.